Across TCGA pan-cancer cohorts, ZNF736P7Y RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated ZNF736P7Y data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher ZNF736P7Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF736P7Y expression acts as an unfavorable survival marker, although some lineages such as HNSC and KIRC show a favorable association.
KIRP, SKCM, and THCA are the cancer types where ZNF736P7Y RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.